Grant: Discovery Grants Program - Individual
University of Western Ontario
$32,000.00
The role of circular RNA AEBP2 in dendritic cells
FY 2020-21
Summary
Circular RNAs (circRNAs) are a new class of endogenously expressed non-coding RNAs that are produced from back splicing and form a covalently closed loop. Emerging evidence is showing that circRNAs regulate gene expression and play an important role in many physiological processes. However, it remains unknown whether circRNAs participate in the development of dendritic cells (DCs) that are the centre of the immune system.
DCs are unique professional antigen presenting cells capable of bridging the innate immune system and the adaptive immune system. New molecular regulators involved in DC development wait to be unveiled to fully understand the development and function of DCs despite advancement made in understanding DC development and function. Our recent results from circRNA microassay assays suggest that circRNA may be a new interesting regulators of DCs, as our preliminary data show that circRNAs are abundantly expressed in DCs and the expression profiles of circRNAs are significantly different between mature DCs (mDCs) and immature DCs (imDCs). circular RNA AEBP2 (circAEBP2) is one of these altered circRNAs and signifcantly up-regulated in mDCs. Additionally, treatment with TGF beta induces imDCs and downregulates circAEBP2. Bioinformatics analyses and RNA immunoprecipitate assays (RIP) suggest that circAEBP2 may bind to RelB and STAT1. Therefore, we hypothesize that circAEBP2 is required for DCs to develop and differentate towards mature and immuneogenic DCs through interaction with RelB and STAT1. There are two specific objectives to test our hypothesis:
Aim1: To investigate the role of circAEBP2 in DCs. We will culture bone marrow derivd DCs, transfect DCs with circAEBP2 siRNA to knockdown circAEBP2 or with circAEBP2 expression plasmids to upregulate circAEBP2, then assess the maturation status and function of DCs (to activate and polarize T cells and induce regulatory T cells and exhausted T cells) in mixed lymphocyte reactions (MLR) .
Aim 2: To determine the molecular mechanisms by which circAEBP2 regulates DCs. We will peroform a series of RIP assays on circAEBP2 overe-expressed DCs to pull down circAEBP2 bound proteins using circAEBP probes, and to pull down bound circRNAs using antibodies against RelB and STAT1 protein, followed by Western blotting and qRT-PCR, to determine the interaction of circAEBP2 and those proteins.
The goals of the present study are to explore a new role of circRNA and to discover new molecular regulators determining DC development, differentiation and function, which are the fundamental basic scientific questions. The proposed research is at the cutting-edge in the field of circRNA and immunology. It will offer an excellent training environment for trainees.
The success of the study will provide insights into new molecular regulators in DC development and impact of circAEBP2 on DCs. This study will advance our knowledge on circRNA, post-transcriptional regulation and DCs.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2019-04545
Name nom
Zheng, Xiufen
Department département
Pathology
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2019
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5105
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell differentiation
Research subject fr
Différenciation cellulaire
Installment
inst:2-5
Partie
4
Nb partie
5
Application title
The role of circular RNA AEBP2 in dendritic cells
Keyword
NSERC
Application summary
Circular RNAs (circRNAs) are a new class of endogenously expressed non-coding RNAs that are produced from back splicing and form a covalently closed loop. Emerging evidence is showing that circRNAs regulate gene expression and play an important role in many physiological processes. However, it remains unknown whether circRNAs participate in the development of dendritic cells (DCs) that are the centre of the immune system.
DCs are unique professional antigen presenting cells capable of bridging the innate immune system and the adaptive immune system. New molecular regulators involved in DC development wait to be unveiled to fully understand the development and function of DCs despite advancement made in understanding DC development and function. Our recent results from circRNA microassay assays suggest that circRNA may be a new interesting regulators of DCs, as our preliminary data show that circRNAs are abundantly expressed in DCs and the expression profiles of circRNAs are significantly different between mature DCs (mDCs) and immature DCs (imDCs). circular RNA AEBP2 (circAEBP2) is one of these altered circRNAs and signifcantly up-regulated in mDCs. Additionally, treatment with TGF beta induces imDCs and downregulates circAEBP2. Bioinformatics analyses and RNA immunoprecipitate assays (RIP) suggest that circAEBP2 may bind to RelB and STAT1. Therefore, we hypothesize that circAEBP2 is required for DCs to develop and differentate towards mature and immuneogenic DCs through interaction with RelB and STAT1. There are two specific objectives to test our hypothesis:
Aim1: To investigate the role of circAEBP2 in DCs. We will culture bone marrow derivd DCs, transfect DCs with circAEBP2 siRNA to knockdown circAEBP2 or with circAEBP2 expression plasmids to upregulate circAEBP2, then assess the maturation status and function of DCs (to activate and polarize T cells and induce regulatory T cells and exhausted T cells) in mixed lymphocyte reactions (MLR) .
Aim 2: To determine the molecular mechanisms by which circAEBP2 regulates DCs. We will peroform a series of RIP assays on circAEBP2 overe-expressed DCs to pull down circAEBP2 bound proteins using circAEBP probes, and to pull down bound circRNAs using antibodies against RelB and STAT1 protein, followed by Western blotting and qRT-PCR, to determine the interaction of circAEBP2 and those proteins.
The goals of the present study are to explore a new role of circRNA and to discover new molecular regulators determining DC development, differentiation and function, which are the fundamental basic scientific questions. The proposed research is at the cutting-edge in the field of circRNA and immunology. It will offer an excellent training environment for trainees.
The success of the study will provide insights into new molecular regulators in DC development and impact of circAEBP2 on DCs. This study will advance our knowledge on circRNA, post-transcriptional regulation and DCs.